Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FIRST HALF OF 2025
Biofrontera AG reported its financial results for the first half of 2025, showing a 21.5% increase in total revenue to 8,762 TEUR compared to 7,206 TEUR in the same period of 2024. The growth was driven by strong performance in European markets, particularly Germany, where revenue rose by 24%. Despite a net loss of 3,692 TEUR, the company noted significant improvements in EBITDA and gross profit. The restructuring with Biofrontera Inc. is expected to minimize risks in the U.S. market and strengthen its European presence.
pressetext·